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Introduction: This report characterizes a syndrome of granuloma-
tous inﬁltration presenting as unexplained ventricular arrhyth-
mias with adenopathy anywhere in body. Patients without
obstructive coronary artery disease with signiﬁcant lymph nodes
were evaluated for tuberculosis and sarcoidosis. The aim of our
study is to identify the spectrum of clinical manifestations and the
various imaging features on different imaging modalities in dif-
ferent types of granulomatous cardiomyopathies and their
response to treatment.
Methods: It is a retrospective as well as prospective observational
study of all patients clinically diagnosed as granulomatous cardi-
omyopathy and subsequently conﬁrmed by imaging and standard
laboratory diagnostic test to have granuloma or granulomatous
disease elsewhere in body. Patients having ischemic heart disease
were excluded.
Results: A total of 9 patients were included with mean age of
presentation 47 years. Mediastinal adenopathy with mid-myocar-
dial scar and/or focal myocardial inﬂammation was observed in 7
patients. None of the patients had symptoms of extracardiac
disease. Evidence of tuberculosiswas present in 44.4%. Themedian
follow-up was 6 months. 8 patients had mediastinal lymphadeno-
pathy, one had axillary and one had additional extra mediastinal
lymphadenopathy.
55.5% were female, 88.8% (8 of 9 patients) had ventricular tachy-
cardia and 11.2% had complete heart block. VT recurred despite
initial treatment in 87%. Addition of disease-speciﬁc therapy abol-
ished further recurrences in 71% of them.
Conclusion: Patients with granulomatous cardiomyopathy usually
presents as unexplained ventricular arrhythmias or occasionally
atrioventricular nodal block with preserved or compromised ven-
tricular function. It is a syndrome of arrhythmogenic myocarditis
with granulomatous lymphadenopathy due to myocardial tuber-
culosis or cardiac sarcoidosis. This entity is optimally managed
with a combination of disease-speciﬁc therapy and antiarrhythmic
measures.
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Introduction: Prosthetic heart valve thrombosis (PHVT) is an
uncommon but serious complication of valve replacement. As
compared to developed countries where the reported incidence
of PHVT ranges from 0.3% to 3% per year, Indian studies have
quoted the incidence to be as high as 6% in the initial 6 months of
valve implantation. Previous studies have demonstrated variety of
risk factors [compliance to oral anticoagulation (OAC), depressed
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Baseline Features of patients with unexplained arrhythmias due to Sarcoidosis/Tuberculosis
Patient
serial No.
Age
(years)
Sex LVEF
(%)
Arrhythmia
presentation
Site of adenopathy
on imaging
Biopsy
diagnosis
Tuberculin
skin test
Diagnosis Disease speciﬁc
treatment
Antiarrhythmic
treatment
1 52 F C VT M TB P TB ATT AAD
2 35 M C VT M S N CS PDN/Mtx AAD + ICD
3 52 F C VT M GIUE P CS/TB ATT + PDN/Mtx AAD
4 42 F C VT M S N CS PDN/Mtx AAD + ICD
5 53 M C VT M S N CS PDN AAD + ICD
6 39 M No CHB M s N CS TPI + PDN –
7 41 F C VT M GIUE N CS/TB ATT + PDN AAD + ICD
8 61 F c VT M, C GIUE N CS PDN AAD + ICD
9 51 M C VT Axillary TB P TB ATT AAD
M – male, F – female, No – normal, C – compromised, VT – ventricular tachycardia, CHB – complete heart block, S – sarcoidosis, TB – tuberculosis, GIUE –
granulomatous inﬂammation of undetermine etiology, M –mediastinal, C – cervical, P – positive, N – negative, ATT – antituberculous therapy, CS – cardiac
sarcoidosis, PDN – prednisolone, Mtx – methotrexate, AAD – antiarrhythmic drug, ICD – implantable cardioverter deﬁbrillator.
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